Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹57Cr
Rev Gr TTM
Revenue Growth TTM
47.26%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

YASHCHEM
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 80.2 | 185.5 | 31.1 | -8.4 | -35.9 | -57.7 | 28.4 | 44.5 | 19.9 | 122.3 | 58.0 | 25.5 |
| 39 | 31 | 17 | 18 | 29 | 11 | 23 | 27 | 30 | 29 | 37 | 34 |
Operating Profit Operating ProfitCr |
| 0.4 | 4.3 | 10.2 | 4.8 | -17.1 | 17.0 | 4.5 | -0.1 | -0.3 | 4.0 | 3.2 | 0.8 |
Other Income Other IncomeCr | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 2 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 2 | 2 | 1 | -4 | 2 | 1 | 0 | 1 | 1 | 1 | 1 |
| 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -30.8 | 44.7 | -20.5 | 52.9 | -585.7 | -7.3 | -28.5 | -88.5 | 114.4 | -31.8 | -15.7 | 1,800.0 |
| 1.6 | 4.3 | 7.9 | 2.8 | -12.3 | 9.3 | 4.4 | 0.2 | 1.5 | 2.9 | 2.4 | 3.3 |
| 2.5 | 1.0 | 0.7 | 0.4 | -2.4 | 0.9 | 0.6 | 0.3 | 0.2 | 0.6 | 0.7 | 0.8 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 9.1 | 16.3 | -20.7 | -28.0 | 73.2 | -12.8 | 11.2 | 0.4 | 39.6 |
| 77 | 83 | 95 | 75 | 53 | 94 | 85 | 95 | 92 | 130 |
Operating Profit Operating ProfitCr |
| 0.8 | 2.5 | 3.6 | 4.3 | 5.4 | 3.7 | -0.1 | 0.0 | 3.5 | 2.0 |
Other Income Other IncomeCr | 1 | 1 | 0 | 1 | 1 | 2 | 6 | 2 | 2 | 3 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 3 | 4 | 4 | 4 | 5 | 5 | 0 | 4 | 5 |
| 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
|
| | 214.2 | 32.9 | 13.6 | -14.8 | 35.7 | 11.8 | -91.4 | 763.1 | 18.1 |
| 0.8 | 2.3 | 2.6 | 3.8 | 4.5 | 3.5 | 4.5 | 0.3 | 3.0 | 2.5 |
| 0.6 | 1.8 | 2.2 | 2.3 | 2.5 | 3.3 | 2.7 | -0.3 | 2.0 | 2.3 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 4 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| 9 | 4 | 7 | 10 | 12 | 15 | 19 | 25 | 27 | 29 |
Current Liabilities Current LiabilitiesCr | 29 | 23 | 25 | 24 | 26 | 32 | 27 | 20 | 25 | 37 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 1 | 2 | 2 | 2 | 4 | 3 | 2 | 3 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 42 | 37 | 44 | 46 | 45 | 54 | 50 | 62 | 69 | 82 |
Non Current Assets Non Current AssetsCr | 0 | 3 | 7 | 9 | 14 | 14 | 18 | 16 | 16 | 17 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -2 | 1 | 0 | 0 | 1 | -3 | 5 | -18 | -1 |
Investing Cash Flow Investing Cash FlowCr | 0 | -3 | -2 | 0 | -4 | 0 | -6 | 3 | 0 |
Financing Cash Flow Financing Cash FlowCr | 2 | 2 | 3 | -1 | 4 | 4 | 1 | 15 | 0 |
|
Free Cash Flow Free Cash FlowCr | -2 | 0 | -1 | 0 | 0 | -3 | 1 | -18 | -1 |
| -351.2 | 37.1 | -16.0 | 10.2 | 28.4 | -101.5 | 118.7 | -5,350.7 | -26.0 |
CFO To EBITDA CFO To EBITDA% | -328.3 | 34.6 | -11.8 | 8.8 | 23.3 | -94.7 | -6,709.2 | 70,611.6 | -22.4 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 17 | 54 | 89 | 72 | 43 | 60 | 71 | 57 | 50 |
Price To Earnings Price To Earnings | 27.0 | 29.6 | 38.9 | 30.1 | 22.3 | 23.9 | 25.5 | 0.0 | 24.2 |
Price To Sales Price To Sales | 0.2 | 0.6 | 0.9 | 0.9 | 0.8 | 0.6 | 0.8 | 0.6 | 0.5 |
Price To Book Price To Book | 1.3 | 3.9 | 5.2 | 3.5 | 1.9 | 2.4 | 2.4 | 1.6 | 1.3 |
| 29.5 | 26.8 | 25.6 | 21.3 | 15.5 | 18.9 | -1,195.4 | -2,651.0 | 18.1 |
Profitability Ratios Profitability Ratios |
| 3.2 | 3.7 | 5.8 | 6.5 | 8.1 | 5.9 | 1.8 | 3.3 | 5.3 |
| 0.8 | 2.5 | 3.6 | 4.3 | 5.4 | 3.7 | -0.1 | 0.0 | 3.5 |
| 0.8 | 2.3 | 2.6 | 3.8 | 4.5 | 3.5 | 4.5 | 0.3 | 3.0 |
| 8.3 | 19.6 | 20.3 | 19.3 | 14.8 | 15.3 | 14.8 | 3.3 | 10.9 |
| 4.7 | 14.1 | 15.2 | 14.3 | 11.1 | 13.3 | 13.1 | 0.9 | 7.5 |
| 1.5 | 4.8 | 5.1 | 5.4 | 4.2 | 5.0 | 5.6 | 0.4 | 3.3 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
**Yash Chemex Limited**, headquartered in Ahmedabad and established in **2006**, is a prominent Indian player in the **import, export, and trading** of chemicals, dyes, and intermediates. While traditionally a trading-heavy enterprise, the company is currently undergoing a strategic transition toward **direct manufacturing** and **specialty chemical production** through a network of specialized subsidiaries and new industrial acquisitions.
---
### **Core Business Verticals & Market Positioning**
The company operates through a single reportable segment—the **Chemical Business**—but services diverse industrial applications through three strategic pillars:
* **Specialty Chemicals:** High-value, niche chemicals designed for specific industrial performance requirements.
* **Agro Chemicals:** Products catering to the agricultural sector, currently benefiting from the global **"China Plus One"** supply chain diversification strategy.
* **Chemical Intermediaries:** Essential raw materials and inputs for the global dyes and textile industries.
The company leverages its strategic location in Gujarat—India’s chemical hub—to maintain a competitive edge through high-volume trading, quality control, and an established domestic client network.
---
### **Group Structure & Manufacturing Ecosystem**
Yash Chemex extends its operational reach through a structured hierarchy of subsidiaries and associates, shifting the group from a pure trading model to an integrated manufacturing entity.
| Entity | Relationship | Principal Activities & Strategic Role |
| :--- | :--- | :--- |
| **Yasons Chemex Care Limited** | **Material Subsidiary** (51.47% holding) | Focuses on manufacturing dyes, intermediates, and **FMCG** products under the brand **PLXO**. Listed on **NSE Emerge** in 2023. |
| **K.P International Limited** | Subsidiary | Operates a dedicated manufacturing facility at **GIDC, Dahej**; operational since **June 2021**. |
| **Rishit Polysurf LLP** | Associate/Acquisition | Provides specialized expertise in specialty chemicals and FMCG product manufacturing. |
**Operational Infrastructure:**
* **Phase-III Expansion:** As of late 2023, the company is progressing with **Phase-III production expansion** at its subsidiary facilities to drive future volume growth.
* **Direct Manufacturing Entry:** The parent company has secured a **Plot at Saykha GIDC** to initiate its own direct manufacturing activities, moving away from third-party sourcing.
* **Global Footprint:** The group maintains an active export network across the **USA, Spain, Turkey, Brazil, Thailand, Korea, Mexico, Japan, and Indonesia**.
---
### **Sector Dynamics: Dyes, Pigments, and Intermediates**
Yash Chemex operates within a global market valued at **USD 38.2 billion** in **2022**, projected to grow at a **CAGR of 5.3%** through **2030**.
#### **Product Segment Outlook**
* **Reactive Dyes:** The company’s dominant segment (holding **>57%** market share in 2022). These are essential for **cotton and rayon** textiles due to their **covalent bonding** properties. This segment is expected to witness the **fastest CAGR** through 2030.
* **Organic Pigments:** Projected to grow at **5.7% CAGR**, driven by the internal substitution of inorganic pigments due to **stringent environmental regulations**.
* **Inorganic Pigments:** While currently holding a majority share in construction and industrial coatings, this segment faces increasing regulatory scrutiny, favoring the company’s shift toward organic alternatives.
---
### **Financial Performance & Capital Management**
The company has demonstrated a recovery in profitability despite a slight contraction in standalone revenue, focusing on optimizing its capital structure.
**Standalone Financial Summary**
| Metric | FY 2024-25 | FY 2023-24 |
| :--- | :--- | :--- |
| **Net Revenue from Operations** | **₹57.96 crore** | **₹61.35 crore** |
| **Profit Before Tax (PBT)** | **₹1.97 crore** | **₹(1.56) crore (Loss)** |
| **Total Comprehensive Income** | **₹1.27 crore** | **₹(0.36) crore (Loss)** |
**Consolidated Historical Performance**
| Metric (Rs. in Crore) | FY 2023-24 (H1) | FY 2022-23 | FY 2021-22 |
| :--- | :--- | :--- | :--- |
| **Consolidated Revenue** | **16.99** | **85.33** | **97.84** |
| **Consolidated Net Profit (PAT)** | **1.58** | **4.57** | **3.95** |
**Capital Structure & Liquidity:**
* **Net Gearing Ratio:** Maintained at a stable **29.90%** (as of March 2024).
* **Debt Profile:** Total debt stands at **Rs. 7.13 crore**, primarily utilized for working capital.
* **Subsidiary Capitalization:** **Yasons Chemex Care Limited** successfully raised **₹20.57 crore** via an **SME IPO** in July 2023 to fund expansion for the next **5 years**.
* **Investment Capacity:** Shareholders have authorized an investment limit of up to **₹100 crore** for loans and guarantees to support chemical ventures.
---
### **Strategic Growth Drivers & "Make in India" Alignment**
The company is positioning itself to capture a share of the Indian chemical sector, which is targeted to reach **USD 304 Billion by 2025**.
* **Customization & R&D:** Transitioning from generic trading to the production of **customized products** specifically for domestic dyes and intermediates clients.
* **Digital Expansion:** Utilizing **e-commerce platforms** alongside traditional brick-and-mortar distribution to reach global construction and textile markets.
* **Policy Tailwinds:** Leveraging **100% FDI** allowance, **PLI schemes**, and the **"Atmanirbhar Bharat"** initiative to replace imports with indigenous manufacturing.
* **Leadership Continuity:** Recent 5-year appointments of **Mr. Dhanik Jayeshkumar Mehta** (Independent Director) and **Mrs. Dimple Pritesh Kumar Shah** (Whole-time Director) ensure long-term governance stability.
---
### **Risk Profile & Mitigation Strategies**
#### **1. Market & Macroeconomic Risks**
* **Import Threats:** Vulnerability to "cheap imports" from **China** (due to overcapacity) and **Russia** (due to currency devaluation).
* **Input Volatility:** High exposure to **Benzene** and oil price cycles. A **50 bps** increase in interest rates is estimated to impact PBT by **Rs. 6.29 lakhs**.
* **Currency Exposure:** Primary exposure to **USD** for stock purchases; the company currently does not use material derivative contracts for hedging.
#### **2. Regulatory & Labor Risks**
* **New Labour Codes:** The transition to **four New Labour Codes** in late **2025** is being monitored; however, no material financial impact is currently expected.
* **Gratuity Obligations:** Legislative changes to the **Payment of Gratuity Act** could impact defined benefit obligations.
* **Environmental Compliance:** Increasing pressure for the **efficient removal of hazardous pollutants** requires ongoing investment in advanced manufacturing technologies.
#### **3. Operational Risks**
* **Manpower:** A persistent shortage of **skilled manpower** in the Indian chemical sector remains a hurdle for scaling manufacturing operations.
* **Credit Risk:** Managed through **Expected Credit Loss (ECL)** models; trade receivables stood at **Rs. 22.55 crore** (March 2023) with a minimal allowance of **Rs. 10.43 lakhs**.